Hikma Pharmaceuticals
Hikma focuses on a wide range of generic, branded generic and in licensed pharmaceutical products.
Launch date
Employees
Market cap
$5.6b
Enterprise valuation
$6.6b (Public information from Sep 2024)
Share price
£19.60072 HIK.L
Company register number 05557934
London England (HQ & founding location)
Corporate Venture Fund: Hikma Ventures
Authorizing premium user...